Is the predictive power of previous fractures for new spine and non-spine fractures associated with biochemical evidence of altered bone remodelling? The EPOS study

Clinica Chimica Acta

Volumn 322, Issue 1-2, 2002, Pages 121-132

  Vergnaud, P ^a   Lunt, M ^b,c   Scheidt Nave, C ^d   Poor, G ^c   Gennari, C ^f   Hoszowski, K ^e   Lopes Vaz, A ^h   Reid, D M ⁱ   Benevolenskaya, L ^j   Grazio, S ^k   Weber, K ^l   Miazgowski, T ^m   Stepan, J J ⁿ   Masaryk, P ^o   Galan, F ^p   Bruges Armas, J ^q   Lorenc, R ^g   Havelka, S ⁿ   Perez Cano, R ^o   Seibel, M ^d   Armbrecht, G ^r   Kaptoge, S ^b   O'Neill, T W ^c   Silman, A J ^c   Felsenberg, D ^r   Reeve, J ^b,s   Delmas, P D ^a   more..

^a INSERM   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ARC Epidemiology Research Unit   (United Kingdom)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

^f UNIVERSITY OF SIENA   (Italy)

^g PKP Hospital   (Poland)

^h HOSPITAL DE SÃO JOÃO   (Portugal)

ⁱ UNIVERSITY OF ABERDEEN   (United Kingdom)

^j V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^k KBC Zagreb   (Croatia)

^l UNIVERSITY HOSPITAL GRAZ   (Austria)

^m POMERANIAN MEDICAL UNIVERSITY   (Poland)

ⁿ CHARLES UNIVERSITY   (Czech Republic)

^o NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^p UNIVERSITY OF SEVILLE   (Spain)

^q Hospital de Santo   (Portugal)

^r CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^s ADDENBROOKE S HOSPITAL   (United Kingdom)

more..

Author keywords

Biochemical markers; Bone densitometry; Bone turnover; Epidemiology; Fractures; Osteoporosis

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN; COLLAGEN TYPE 1; CREATININE; OSTEOCALCIN; PHOSPHATE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; RISK ASSESSMENT; SPINE FRACTURE;

AGED; AGING; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CALCIUM; COLLAGEN; CREATININE; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OSTEOCALCIN; PHOSPHATES; PROGNOSIS; RECURRENCE; SEX CHARACTERISTICS; SPINAL FRACTURES; VITAMIN D;

EID: 18444406561     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00164-X     Document Type: Article

References (49)

1. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
2. Bone density variation and its effects on risk of vertebral deformity in men and women studied in 13 European centres: The EVOS study
3. Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis
4. Rates and determinants of vertebral fracture incidence in European men and women
5. Bone microdamage and skeletal fragility in osteoporotic and stress fractures
6. The effects of ageing and changes in mineral content in degrading the toughness of human femora
7. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
8. Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam study
9. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study
10. Low bone mass and fast rate of bone loss at menopause - Equal risk factors for future fracture. A 15 year follow-up study
11. Serum bone alkaline phosphatase and calcaneus bone density predict fractures; A prospective study
12. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fractures: A retrospective and prospective population-based study of women
13. Design and development of a questionnaire for use in a multicentre study of vertebral osteoporosis in Europe: The European vertebral osteoporosis study (EVOS)
14. Differences in the characteristics of responders and nonresponders in a prevalence survey of vertebral osteoporosis
15. The prevalence of vertebral deformity in European men and women: The European vertebral osteoporosis study
16. Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women
17. Variation in vertebral height ratios in population Studies
18. Pravalenz der vertebralen Wirbelkorperdeformationen bei Frauen und Mannern in Deutschland
19. The serum CTx™ one step ELISA. The first application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type 1 collagen
20. Immunoassay for quantifying type 1 collagen degradation products in urine evaluated
21. The assessment of vertebral deformity: A method for use in population studies and clinical trials
22. A statistical method to minimise magnification errors in serial vertebral radiographs
23. Measurement imprecision in digital vertebral morphometry of spinal radiographs obtained in the EPOS study: Consequences for the identification of prevalent and incident deformities
24. Validity of self-report of fractures: Results from a prospective study in men and women across Europe
25. Population-based geographic variations in DXA bone density in Europe: The EVOS study
26. European semi-anthropomorphic spine phantom for the calibration of bone densitometers: Assessment of precision, stability and accuracy
27. The European Spine Phantom - A tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT
28. Changes in bone mass and bone turnover following distal forearm fracture
29. Prediction of bone loss in postmenopausal women
30. Preanalytic variability of biochemical markers of bone turnover
31. The use of biochemical markers of bone turnover in osteoporosis
32. Markers of bone turnover for monitoring treatment of osteoporosis with anti-resorptive drugs
33. Markers of bone turnover for the prediction of fracture risk
34. Afternoon-sampled serum type 1 collagen breakdown product (serum CTX) predicts hip fracture in elderly women: Results of the EPIDOS study
35. Serum undercaroxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study
36. Strong prediction of fracture among older adults by the ratio of carboxylated to total serum osteocalcin
37. Which fractures are associated with high bone resorption in elderly women? The Rotterdam Study
38. Serum Markers of bone turnover and fractures of the hip and spine: A prospective study
39. Circannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: A prospective study
40. Geographic differences in bone turnover: Data from a multinational study in healthy postmenopausal women
41. Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: Results from the European prospective osteoporosis study (EPOS)
42. Prevalent vertebral deformity predicts future hip though not distal forearm fracture: Results from the European prospective osteoporosis study
43. Determinants of the size of incident vertebral deformities in European men and women in the 6th-9th decades of age: The European prospective osteoporosis study (EPOS)
44. Prediction of osteoporotic fracture by bone densitometry and COL1A1 genotyping: A prospective, population-based study in men and women
45. Age-related changes in the biochemical properties of human cancellous bone collagen: Relationship to bone strength
46. Structure of the femoral neck in hip fracture: Cortical bone loss in the inferoanterior to superoposterior axis
47. A novel mechanism for the induction of the increased cortical porosity in cases of intra-capsular hip fracture
48. Intracapsular hip fracture: Increased cortical remodelling in the thinned and porous anterior region of the femoral neck
49. Mechanical consequences of bone loss in cancellous bone